Compile Data Set for Download or QSAR
Report error Found 1541 Enz. Inhib. hit(s) with Target = 'Bromodomain-containing protein 4 [42-168]'
TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737462(US20250136619, Compound I-24)
Affinity DataKd:  275nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737463(US20250136619, Compound I-26)
Affinity DataKd:  275nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737464(US20250136619, Compound I-28)
Affinity DataKd: >2.50E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737465(US20250136619, Compound I-29)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737489(US20250136619, Compound I-32)
Affinity DataKd:  1.50E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM737488(US20250136619, Compound I-34)
Affinity DataKd:  275nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/3/2025
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209487(US9266891, III-28 | US10328074, Example III-28 | U...)
Affinity DataIC50: 1nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209474(US9266891, III-15 | US10328074, Example III-15 | U...)
Affinity DataIC50: 3nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209481(US9266891, III-22 | US10328074, Example III-22 | U...)
Affinity DataIC50: 3nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209482(US9266891, III-23 | US10328074, Example III-23 | U...)
Affinity DataIC50: 3nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209457(US9266891, II-1 | US10328074, Example II-1 | US110...)
Affinity DataIC50: 4nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209508(US9266891, III-49 | US10328074, Example III-49 | U...)
Affinity DataIC50: 4nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209475(US9266891, III-16 | US10328074, Example III-16 | U...)
Affinity DataIC50: 5nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209485(US9266891, III-26 | US10328074, Example III-26 | U...)
Affinity DataIC50: 5nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209509(US9266891, III-50 | US10328074, Example III-50 | U...)
Affinity DataIC50: 5nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209460(US9266891, III-1 | US10328074, Example III-1 | US1...)
Affinity DataIC50: 7nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209471(US9266891, III-12 | US10328074, Example III-12 | U...)
Affinity DataIC50: 7nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209491(US9266891, III-32 | US10328074, Example III-32 | U...)
Affinity DataIC50: 7nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209453(US9266891, I-5 | US10328074, Example I-5 | US11077...)
Affinity DataIC50: 8nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209463(US9266891, III-4 | US10328074, Example III-4 | US1...)
Affinity DataIC50: 8nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209480(US9266891, III-21 | US10328074, Example III-21 | U...)
Affinity DataIC50: 8nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209507(US9266891, III-48 | US10328074, Example III-48 | U...)
Affinity DataIC50: 8nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209464(US9266891, III-5 | US10328074, Example III-5 | US1...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209465(US9266891, III-6 | US10328074, Example III-6 | US1...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209467(US9266891, III-8 | US10328074, Example III-8 | US1...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209470(US9266891, III-11 | US10328074, Example III-11 | U...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209472(US9266891, III-13 | US10328074, Example III-13 | U...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209488(US9266891, III-29 | US10328074, Example III-29 | U...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209489(US9266891, III-30 | US10328074, Example III-30 | U...)
Affinity DataIC50: 9nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209473(US9266891, III-14 | US10328074, Example III-14 | U...)
Affinity DataIC50: 10nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209486(US9266891, III-27 | US10328074, Example III-27 | U...)
Affinity DataIC50: 10nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209484(US9266891, III-25 | US10328074, Example III-25 | U...)
Affinity DataIC50: 11nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM400284(US10328074, Example III-47)
Affinity DataIC50: 12nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209512(US9266891, III-53 | US10328074, Example III-53 | U...)
Affinity DataIC50: 12nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM254914(US9493483, 402)
Affinity DataIC50: 13nMpH: 7.0 T: 2°CAssay Description:His/Flag epitope tagged BRD4 BD142-168 was cloned, expressed and purified to homogeneity. BRD4 binding and inhibition was assessed by monitoring the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2017
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209479(US9266891, III-20 | US10328074, Example III-20 | U...)
Affinity DataIC50: 13nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209490(US9266891, III-31 | US10328074, Example III-31 | U...)
Affinity DataIC50: 13nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209510(US9266891, III-51 | US10328074, Example III-51 | U...)
Affinity DataIC50: 13nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM50158612(US9493483, 401 | CHEMBL3787075)
Affinity DataIC50: 14nMpH: 7.0 T: 2°CAssay Description:His/Flag epitope tagged BRD4 BD142-168 was cloned, expressed and purified to homogeneity. BRD4 binding and inhibition was assessed by monitoring the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2017
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209468(US9266891, III-9 | US10328074, Example III-9 | US1...)
Affinity DataIC50: 14nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209496(US9266891, III-37 | US10328074, Example III-37 | U...)
Affinity DataIC50: 14nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209458(US9266891, II-2 | US10328074, Example II-2 | US110...)
Affinity DataIC50: 15nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209494(US9266891, III-35 | US10328074, Example III-35 | U...)
Affinity DataIC50: 15nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209476(US9266891, III-17 | US10328074, Example III-17 | U...)
Affinity DataIC50: 17nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209497(US9266891, III-38 | US10328074, Example III-38 | U...)
Affinity DataIC50: 17nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM50158612(US9493483, 401 | CHEMBL3787075)
Affinity DataIC50: 18nMpH: 7.0 T: 2°CAssay Description:His/Flag epitope tagged BRD4 BD142-168 was cloned, expressed and purified to homogeneity. BRD4 binding and inhibition was assessed by monitoring the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/16/2017
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209452(US9266891, I-4 | US10328074, Example I-4)
Affinity DataIC50: 18nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209469(US9266891, III-10 | US10328074, Example III-10 | U...)
Affinity DataIC50: 18nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209499(US9266891, III-40 | US10328074, Example III-40 | U...)
Affinity DataIC50: 18nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [42-168](Human)
Halda Therapeutics OPCO

US Patent
LigandPNGBDBM209483(US9266891, III-24 | US10328074, Example III-24 | U...)
Affinity DataIC50: 20nMAssay Description:This assay is used to determine whether the compounds inhibit the interaction between the first (BRD4-BD1) or the second (BRD4-BD2) bromodomain of BR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1541 total ) | Next | Last >>
Jump to: